A randomized, double-blind, placebo-controlled, 2-period, multicenter, crossover outpatient study evaluating the efficacy and safety of Zolmitriptan Nasal pray (ZNS) for the acute treatment of migraine headaches in pediatric patients.
Not yet recruiting
Phase of Trial: Phase III
Latest Information Update: 12 Jul 2017
At a glance
- Drugs Zolmitriptan (Primary)
- Indications Migraine
- Focus Therapeutic Use
- 12 Jul 2017 New trial record
- 11 Jun 2017 Enrollment is planned to begin in late 2017 with results expected in 2019. The study will enroll approximately 426 subjects to randomize and treat 288.
- 11 Jun 2017 Trial design presented at the 59th Annual Scientific Meeting of the American Headache Society